Cel-Sci (CVM) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Cel-Sci (CVM) is Moderate Underperform.

The composite score behind that read is -0.42, weighing +0.00 of bullish evidence against -0.42 bearish.

Cel-Sci last closed at $2.42, +4.76% on the session.

Against the IVW growth benchmark the position is +3.84% over the forecast window.

The read is built from 11 underlying insights — 0 bullish and 11 bearish.

Agreement across those insights is 100%.

16 graded predictions for CVM so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Cel-Sci in the 5th percentile on return on equity, where 100 is best.

Cel-Sci is classified under Health Care / Biotechnology, with a market capitalisation of $40.63M.

StockMap tracks Cel-Sci as the 289th largest of the 344 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 180 Moderate Underperform, 152 Neutral, 11 Strong Underperform and 1 Moderate Outperform.

On that composite Cel-Sci ranks 315th of 344 in the group, against a group median of -0.21.